Clinical trial NCT06209840: The Effect of Music Therapy on Upper Extremity Functions and Quality Of Life in Individuals With Cerebral Palsy
Official title: The Effect of Music Therapy on Upper Extremity Functions and Quality Of Life in Individuals With Cerebral Palsy
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Cerebral Palsy
Hemiplegic Cerebral Palsy
Music Therapy
Keywords: Cerebral Palsy
Music Therapy
Upper Extremity
Quality of Life
Lead sponsor: Ankara Yildirim Beyazıt University
Sponsor class: OTHER
First posted: 2024-01-18
Enrollment: 24
Sex: ALL
Minimum age (years): 6
Maximum age (years): 21
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The main purpose of this study is to investigate the effect of music therapy on the upper extremity functions and quality of life of individuals with Cerebral Palsy (CP). The secondary aim is to investigate the effect of music therapy on the sensory functions of the upper extremity in individuals with CP. Adolescent individuals with hemiparetic CP will participate in this study, and the participants will experience music therapy, which is a scientific intervention approach. If music therapy has a positive effect on upper extremity functions, they will be more active in daily life and their quality of life will increase. In the light of these data to be presented, a contribution will be made to the evidence level of music therapy in the literature and to the content of SP upper extremity rehabilitation.


Eligibility criteria: Inclusion Criteria:

* Between the ages of 6-21
* With upper extremity dysfunction
* MACS score between 2-4,
* According to MAS, spasticity severity ranges from (1+) to (3),
* Individuals diagnosed with hemiparetic Cerebral Palsy who are at a cognitive level that can follow simple instructions during applications and evaluations will be included.

Exclusion Criteria:

* Having another neurological disorder
* Having undergone upper extremity orthopedic surgery or Botulinum Toxin A (BTX-A) application in the last 6 months,
* Individuals currently receiving another rehabilitation program in addition to classical physiotherapy for upper extremity rehabilitation will be excluded from the study.

Primary outcomes:
measure: Children's Hand-Use Experience Questionnaire (CHEQ)
timeFrame: Change from baseline at 8 weeks
measure: Abilhand-Kids
timeFrame: Change from baseline at 8 weeks
measure: Selective Control of the Upper Extremity Scale (SCUES)
timeFrame: Change from baseline at 8 weeks
measure: Pediatric Quality of Life Inventory (PedsQL) 3.0 Cerebral Palsy Module
timeFrame: Change from baseline at 8 weeks
Secondary outcomes:
measure: Semmes Weinstein Monofilament Test (SWMT)
timeFrame: Change from baseline at 8 weeks
measure: Two-Point Discrimination
timeFrame: Change from baseline at 8 weeks
measure: Modified Ashworth Scale (MAS)
timeFrame: Change from baseline at 8 weeks
Other outcomes:
measure: The Gross Motor Function Classification System (GMFCS)
timeFrame: Before the start of treatment
measure: The Manual Ability Classification System (MACS)
timeFrame: Before the start of treatment
Locations:
city: Ankara
country: Turkey
facility: Sena ÇARIKCI
Study officials:
affiliation: Ankara Yıldırım Beyazıt University Health Sciences Institute
name: Sena ÇARIKCI, MSc
role: PRINCIPAL_INVESTIGATOR
affiliation: Saglik Bilimleri Universitesi
name: Nezehat Özgül ÜNLÜER, PhD
role: STUDY_CHAIR
affiliation: Anadolu University Health Sciences Institute
name: Şükrü TORUN, MD
role: STUDY_CHAIR
References: